治疗腹和脱水的新型口服补水液 (ORS) 的有效性和安全性:印度患者的一项随机研究
Bridreth Khokhare1, Nutan Agrawal2, Mohammed Siddique2
1Department of Research and Development, Mystical Biotech Pvt. Ltd., Bengaluru, IND.
Cureus
|March 13, 2026
概括
与标准的ORS相比,一种用益生菌丰富的新型口服补水液 (ORS) 显示出更快的症状缓解和更高的急性腹患者满意度. 这种益生菌增强的ORS提供了一个潜在的优越治疗选择.
科学领域:
- 胃肠病学 胃肠病学
- 微生物学 微生物学
- 临床医学 临床医学
背景情况:
- 急性腹是全球脱水相关疾病的重要原因之一.
- 口服补水溶液 (ORS) 是对腹的主要治疗方法,但益生菌可能提供额外的益处.
- 这项研究研究了一种新的益生菌丰富的ORS用于印度急性腹.
研究的目的:
- 评估一种新型益生菌丰富的ORS的疗效和安全性.
- 为了比较印度患者的益生菌丰富的ORS与标准的ORS.
- 评估结果,如腹解决,恢复时间和患者满意度等.
主要方法:
- 一个随机的平行组研究,涉及60名急性腹患者.
- 患者接受了五天的新型ORS (n=45) 或传统的ORS (n=15).
- 疗效结局包括腹发作频率,恢复时间,患者满意度和临床整体印象改善 (CGI-I) 评分.
主要成果:
- 新的ORS组显示了腹发作的更快减少 (0.4vs0.9访问3的平均发作).
- 在新型ORS组中观察到更高的患者满意度 (42.2%"非常满意") 和CGI-I得分 (1.3对1.9) 的更快改善.
- 两种治疗都显示出具有可比安全性配置文件的临床改善.
结论:
- 这种新的益生菌丰富的ORS有效地加速急性腹症状的缓解.
- 这种增强的ORS配方导致了更大的患者满意度.
- 富含益生菌的ORS为治疗急性腹提供了一个有希望的,可能是首选的选择.
更多相关视频
相关概念视频
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
864
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
864
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
603
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
603
Drugs for Treatment of Diarrhea-Predominant IBS
1.0K
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
1.0K
Regulation of Water Intake
2.2K
Osmolality refers to the number of solute particles per kilogram of solvent in a solution. Plasma osmolality specifically indicates the total number of solute particles per kilogram of water in blood plasma. This value reflects the body's hydration status and is tightly regulated through mechanisms controlling water intake and output. While water consumption is a conscious decision, the body has intrinsic regulatory systems to maintain fluid balance. Dehydration, a state of water deficit...
2.2K
Drug Delivery Systems: Different Types
418
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
418
Cholera
153
Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
153


